DAIC

APRIL 6, 2024

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. The composite rate of total heart failure hospitalizations and death from heart failure was also 31% lower among those receiving empagliflozin.

Heart Attack 98

Heart Attack Heart attacks Heart Failure Outpatient 98

DAIC

APRIL 6, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,

Heart Attack 81

Heart Attack Heart attacks Heart Failure Outcomes 81

Dr. Anish Koka

SEPTEMBER 24, 2022

Today’s post on the latest COVID vaccine myocarditis paper gets a big assist from the wicked smart data visualization expert Josh Stevenson ( subscribe to his substack !) In August 2021, the CDC began a study to follow-up cases of myocarditis in the age group at highest risk for myocarditis after mRNA COVID-19 vaccination.

COVID-19 52

COVID-19 Hospital Chest Pain Quality of Life 52